Can you imagine anticipating the struggle between the immune system and a tumor using mathematical tools that understand each patient's uncertainty? Researchers at ESPOL developed an innovative model based on Type-3 Fuzzy Logic that simulates precisely that confrontation. Unlike traditional models, this proposal integrates individual biological variability and delays in the immune response, allowing highly accurate prediction of chaotic patterns and possible tumor relapses. In addition, the study generates clear and interpretable risk maps that facilitate the design of personalized and explainable therapies, aligning with the principles of Explainable Artificial Intelligence (XAI) to support clinical decision-making.

Researchers at AppliedPhysics.org report early evidence that cells respond selectively to mathematically structured sound, not just acoustic power. In an exploratory Biosystems study, Fibonacci based acoustic signals triggered distinct responses across different cell types, suggesting sound can be tuned to cellular size and mechanics rather than applied as brute force.

The findings point to a potential new direction for cancer research: using low intensity, physics driven acoustic design to target physical differences between cancer and healthy cells. While preliminary and based on model organisms, the work opens the door to a future of more precise, less invasive, mechanically selective therapies.

Five new projects for the development of innovative health technologies have been funded by the European Research Council (ERC) at the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) at its sites in Milan, Genoa and Naples. The announcement made today by the European body includes, among the 136 winners across Europe: Annamaria Petrozza and Mario Caironi in Milan, Alessandra Sciutti and Giuseppe Vicidomini in Genoa, and Velia Siciliano in Naples. The three female researchers and the two male researchers at IIT will receive Proof of Concept (PoC) grants of approximately €150,000 each, which will allow them to explore the commercial potential of their research. The fields of application include cancer, dyslexia and diagnostics.